National Cervical Screening Program

27 November 2017


Are you ready for 1 December?

The National Cervical Screening Program (NCSP) changes from 1 December 2017. Participants with a normal screening history will be due for their first Cervical Screening Test two years after their last Pap test.

Further information on the changes and resources to support you can be found at

Online accredited training modules are available at

To guide your clinical practice, please refer to the Guidelines, available at:

The National Cancer Screening Register is going live on 1 December

The National Cancer Screening Register (NCSR) will support the Renewed National Cervical Screening Program and the introduction of the new Cervical Screening Test from 1 December, with the NCSR able to receive and store test results.

At its commencement, the National Cancer Screening Register will not hold screening history data collected before 1 December 2017.  State and territory registers will continue to provide patients’ (pre 1 December) clinical screening histories to laboratories and healthcare providers, until their transition to the NCSR in early 2018.  During this period, the NCSR will provide an update to healthcare providers and specialists, if requested on test information held in the NCSR for their patient.  Results post 1 December will come from the NCSR.

This process will be facilitated through a single call to the appropriate local numbers below:

State of Territory S/T Register Number

1800 777 790


1800 671 693 or 02 8374 5692 (direct local number)

WA, ACT, NT and TAS 13 15 56
SA 1800 901 112 (dirverted to VCS)
VIC 03 9250 0399


Pathology request forms and new pathology MBS items

From 1 December 2017 Pap tests will no longer be eligible for a Medicare rebate.

The pathology Medicare Benefits Schedule (MBS) items for cervical screening performed from 1 December 2017 have changed.
The new Cervical Screening Test (HPV tests; reflex LBC or co-tests (i.e. HPV + LBC) collected and performed from 1 December 2017 should be claimed with the new MBS item number/s.Please refer to the table on the back cover of “Understanding the National Cervical Screening Program Management Pathway: A Guide for Healthcare Providers” found in the healthcare providers pack.
This clinical information must be included on pathology requests to avoid out of pocket costs for your patient.  

Mandatory notifications for colposcopists and pathology practitioners 

Colposcopists are required to notify prescribed cervical screening information to the CMO within 14 days of each colposcopic episode. This is reported through   submitting an Approved Form (Colposcopy and Treatment Form) through the NCSR, and is mandated by the National Cancer Screening Register Rules 2017. The Colposcopy and Treatment Form can be downloaded from the NCSP website,, or from the NCSR website. Once completed, the Form can be mailed or faxed to the National Cervical Screening Program.




Meet the Councillors of the Twelfth RANZCOG Council

Find out more about who is representing you on RANZCOG Council.




Dr Pieter Mourik (AM)

Being recognised in the Australia Day honours was a highlight for this rural medicine advocate.



RANZCOG urges all practitioners to help pregnant women get vaccinated

RANZCOG urges all practitioners to heed the advice issued by RANZCOG and ATAGI which recommends that pregnant women are routinely offered Pfizer or Moderna mRNA vaccine at any stage of pregnancy.